Bank of New York Mellon Corp - PREDICTIVE ONCOLOGY INC ownership

PREDICTIVE ONCOLOGY INC's ticker is and the CUSIP is 74039M200. A total of 25 filers reported holding PREDICTIVE ONCOLOGY INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of PREDICTIVE ONCOLOGY INC
ValueSharesWeighting
Q1 2023$10,174
+6.6%
31,1330.0%0.00%
Q4 2022$9,545
-13.2%
31,133
-0.8%
0.00%
Q3 2022$11,000
-15.4%
31,3760.0%0.00%
Q2 2022$13,000
-58.1%
31,376
-0.7%
0.00%
Q1 2022$31,000
+3.3%
31,5890.0%0.00%
Q4 2021$30,000
-28.6%
31,5890.0%0.00%
Q3 2021$42,000
+2.4%
31,5890.0%0.00%
Q2 2021$41,000
-8.9%
31,589
-15.4%
0.00%
Q1 2021$45,000
-44.4%
37,348
-24.5%
0.00%
Q2 2020$81,000
+200.0%
49,449
+191.7%
0.00%
Q1 2020$27,00016,9530.00%
Other shareholders
PREDICTIVE ONCOLOGY INC shareholders Q2 2021
NameSharesValueWeighting ↓
CARNEGIE MELLON UNIVERSITY 207,144$67,7360.04%
RB Capital Management, LLC 416,693$136,1750.04%
SAX WEALTH ADVISORS, LLC 147,437$48,1820.01%
Prosperity Consulting Group, LLC 14,097$4,6070.00%
PETREDIS INVESTMENT ADVISORS LLC 35,000$11,4380.00%
Csenge Advisory Group 55,000$17,9740.00%
Facet Wealth, Inc. 71,987$23,5250.00%
PSI Advisors, LLC 7,963$2,6020.00%
UBS Group AG 23,922$7,8220.00%
OSAIC HOLDINGS, INC. 32,500$10,6190.00%
View complete list of PREDICTIVE ONCOLOGY INC shareholders